2024 Spring Clinical Research Award


  • United States residents and applicants from outside the United States are welcome to apply.
  • International applicants and institutions are required to submit additional information in accordance with USA Patriot Act and the U.S. Department of Treasury Anti-Terrorist Financing Guidelines (see section VI.10.L in the Program Guidelines).
  • Applicants must be independent investigators. An independent investigator is an individual who is out of fellowship training and whose institution allows them to submit applications for research funding as a Principal Investigator.
  • New or established investigators with no previous work in cystic fibrosis research who wish to apply their expertise to a problem in this area.
  • Candidates who are clinical fellows should apply to the CFF Clinical Fellowship program for the appropriate year.
  • Candidates who are postdoctoral fellows should apply to the CFF Postdoctoral Research Fellowship program.
  • Industry-sponsored research projects are not eligible to apply through this program and instead should consider applying to the Therapeutics Development Awards program. For additional information, please contact grants@cff.org.


The mission of the Cystic Fibrosis Foundation is to cure cystic fibrosis and to provide all people with CF the opportunity to lead long, fulfilling lives by funding research and drug development, partnering with the CF community, and advancing high-quality, specialized care. To achieve this mission, various types of grants and awards are offered to support meritorious research in CF.

The 2024 Spring Clinical Research Awards are offered to provide support for investigator-initiated clinical research projects that have the potential to make an important contribution to the CF Foundation’s mission. Research projects may address diagnosis, treatment, management of disease or symptom, or the pathophysiology of CF using clinical (observational/interventional), translational or epidemiologic study approaches. Applicants must demonstrate access to sufficient numbers of CF patients and appropriate controls.

Funding Considerations

Applicants may request funding of up to $150,000 per year, plus an additional twelve (12) percent indirect costs for single-center clinical studies; and up to $350,000 per year, plus twelve (12) percent indirect costs for multi-center clinical studies, for up to three (3) years. *Up to an additional $100,000 may be available via supplemental funding.

Areas of Encouragement:

The Cystic Fibrosis Foundation regularly assesses its key research priorities to ensure we are on track to accomplish our mission to cure CF and to provide people with CF the opportunity to lead long lives. Applicants are encouraged to align submissions to these priorities to maximize their potential for being funded. Key research priorities for applicants are outlined in further detail in Applicant Resources.

Areas of Encouragement are research topics that are considered gaps in our knowledge in the detection and monitoring, diagnosis, or treatment of a CF complication. A complete list of the Areas of Encouragement can be found in section VI of the Program Guidelines.


Agency Name: 
Cystic Fibrosis Foundation
Contact Name: 
Keiko McFarland
Grant Amount: 
$450,000 - $1,050,000 over three years
Grant Location: 
External Deadline: 
Tuesday, February 13, 2024
Internal Deadline: 
Tuesday, January 30, 2024
Grant Type: 
Grant Area: 
Grant Eligibility: